Stockscreener 앱 받기
27.23
1.04%
0.28
시간 외 거래:
27.35
0.12
+0.44%
전일 마감가:
$26.95
열려 있는:
$25.16
하루 거래량:
18.46M
Relative Volume:
0.80
시가총액:
$6.29B
수익:
$1.24B
순이익/손실:
$101.26M
주가수익비율:
61.89
EPS:
0.44
순현금흐름:
$149.62M
1주 성능:
+1.57%
1개월 성능:
-21.50%
6개월 성능:
+26.30%
1년 성능:
+119.42%
1일 변동 폭
$25.16
$27.44
1주일 범위
$25.16
$29.84
52주 변동 폭
$11.20
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
27.23 | 6.29B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
170.63 | 396.58B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
63.84 | 152.89B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
95.50 | 77.04B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
142.81 | 47.28B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
23.39 | 43.57B | 15.46B | 1.03B | 1.34B | 0.53 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers Health, Inc. (HIMS) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers - The Globe and Mail
Why Hims & Hers Health, Inc. (HIMS) Declined on Wednesday - MSN
HIMS Stock: Ready To Bounce Back From $30? - Nasdaq
Long Term Trading Analysis for (HIMS) - news.stocktradersdaily.com
BofA maintains Hims & Hers stock underperform with $22 target - Investing.com
BofA maintains Hims & Hers stock underperform with $22 target By Investing.com - Investing.com UK
Hims & Hers health CFO sells $330,081 in stock By Investing.com - Investing.com India
Hims & Hers health chief legal officer sells $280,314 in stock - Investing.com Australia
Hims & Hers health CFO sells $330,081 in stock - Investing.com
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know - Yahoo Finance
Robinhood, AppLovin, Hims & Hers Health, Sleep Number, and Covenant Logistics Shares Plummet, What You Need To Know | FinancialContent - FinancialContent
Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it - Yahoo Finance
BofA keeps Hims & Hers stock at underperform, target at $22 By Investing.com - Investing.com India
Lobbying Update: $60,000 of HIMS & HERS HEALTH INC. lobbying was just disclosed - Nasdaq
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 - The Joplin Globe
Is Hims Stock a Buy, Sell, or Hold? - theafricalogistics.com
8,601 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Bought by O Shaughnessy Asset Management LLC - Defense World
InvestingPro’s Fair Value model predicted HIMS stock’s dramatic correction By Investing.com - Investing.com Canada
Truist Financial Has Lowered Expectations for Hims & Hers Health (NYSE:HIMS) Stock Price - Defense World
Why Hims & Hers Stock Just Collapsed - AOL.com
Hims & Hers Health, Inc. (HIMS) Rises But Trails Market: What Investors Should Know - Yahoo
Jefferies raises Hims & Hers stock target to $25, maintains hold - Investing.com Canada
Hims & Hers, at a crossroads, wants to be the Netflix of healthcare - Sherwood News
Hims & Hers health COO Melissa Baird sells $910,687 in stock - Investing.com Canada
Here’s Cedar Grove Capital Management’s Take Away from Its Short Position Hims and Hers Health (HIMS) - MSN
Here’s Cedar Grove Capital Management’s Takeaway from Its Short Position Hims and Hers Health (HIMS) - Insider Monkey
Hims’ Weight Loss Expansion: Real Growth or Just Hype? - MarketBeat
Truist Cuts Price Target on Hims & Hers Health to $33 From $39, Keeps Hold Rating - MarketScreener
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know - Yahoo Finance
Here’s Why Hims & Hers Health (HIMS) is Growing Revenue And Profitability - Insider Monkey
Market Update: Trident Digital Tech Holdings, Tesla, Hims & Hers Health, and SoFi Technologies Experience Notable Market Activity - Insider Monkey
Sei Investments Co. Reduces Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know - MSN
Hims & Hers health executive sells $63,402 in stock By Investing.com - Investing.com India
Hims & Hers health PAO Becklund Irene sells shares worth $63,402 - Investing.com Canada
Hims & Hers health executive sells $63,402 in stock - Investing.com
Hims & Hers CFO Okupe Oluyemi sells $338,833 in stock - Investing.com
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings - Yahoo Finance
Hims & Hers : Telehealth's billion-dollar surge - MarketScreener
Zepbound Now Available Through Hims & Hers - Endocrinology Advisor
‘Hold the Phone,’ Says Morgan Stanley on Hims & Hers Health Stock (HIMS) - markets.businessinsider.com
Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market?There Is Only One Winner (NYSE:LLY) - Seeking Alpha
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.28%
자본화:
|
볼륨(24시간):